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Amid the flurry of grant writing and experimentation, statistical analysis sometimes gets less attention than
it requires. Here, we describe fully the considerations that should go into the employment of the statistical
two-sample t test.The biological significance of immunolog-
ical data is paramount in their interpreta-
tion. Nevertheless, immunological data
are variable, and because statistical sci-
ence aims to make sense of variability,
statistical methods are not superfluous
to immunology. The most informative in-
terpretation of experimental data emerges
from a combination of biological and sta-
tistical insight.
Proper statistical analysis of results can
only be achieved if the researcher has
some understanding of statistical theory
and of the potential that it offers when
summarizing data and drawing conclu-
sions from them. Here, we concentrate
on the frequently misused two-sample t
test, using an experimental data set to
illustrate the appropriate application of
this test in immunological research.
Units of Analysis: What Is Being
Analyzed in an Experiment?
Before undertaking any statistical analy-
sis, it is essential to be clear about what
is being analyzed. The ‘‘unit of analysis’’
(Altman and Bland, 1997), also called
the experimental unit, is the smallest
unit of replication that can be assigned
at random to a ‘‘treatment’’ (see this
and other key definitions in Box 1).
Take, for example, an in vivo experiment
designed to assess whether a particular
experimental infection upregulates inter-
leukin-10 (IL-10) production in CD4+ T
cells in mice (Box S1A Experiment 1
and Figure S1). Because each animal’s
spleen is processed separately, the unit
of analysis is the individual mouse in
which the measurement of interest is
the CD4+ T cell IL-10 Median Fluores-
cence Intensity (MFI).288 Immunity 28, March 2008 ª2008 ElseviOften in immunological experiments, how-
ever, it is not feasible to assess mice indi-
vidually, and it isnecessary topoolmaterial
from several animals in order to carry out
the experiment. For example, in pooling
CD4+ T cells from five animals to coculture
with primed and unprimed dendritic cells in
the wells of a tissue-culture plate, the unit
of analysis in this in vitro experiment (Box
S1B) is the well and not the mouse. The
result of a statistical hypothesis test in
such an experiment refers to one pooled
cell population. Conclusions cannot be
drawn about the behavior of mouse T cells
in general until repeated experiments with
independently derived cell populations
have been conducted. Whether the unit
of analysis is the mouse or the well, the cor-
rect application of the two-sample t test to
the data must provide conclusions that
relate to the relevant unit of analysis.
The Two-Sample t Test
and the p Value
Currently, the two-sample t test (also
called the ‘‘independent samples’’ or ‘‘un-
paired’’ t test) is one of the most commonly
used statistical hypothesis tests in immu-
nological research. Because it is often
performed with computer software, only
a basic explanation of the mechanics of
the test is provided (Box S2), although fur-
ther details can be obtained from standard
statistical textbooks (e.g., Petrie and Wat-
son, 2006). However, to apply the t test
correctly, it is important for immunologists
to understand the concepts and terminol-
ogy underlying hypothesis testing.
The two-sample t test compares the
means of two groups. Generally, it is not
possible to study the whole population
of observations, so a representative sam-
ple is used to make inferences about theer Inc.population. More specifically, the sample
mean is used as an estimate of the true
mean in the population. In the two-sample
t test, the population means are com-
pared by use of the sample mean re-
sponses of the relevant units of analysis
when each unit receives one of two treat-
ments. The result is used to assess
whether any apparent difference in means
reflects a real difference or is due to ran-
dom variation.
With regard to the example of whether
infection induces IL-10 production in
CD4+ T cells (Box S1A Experiment 1 and
Figure S1), the two-sample t test is con-
ducted to test the null hypothesis (the
hypothesis of ‘‘no effect’’) that the true
group-mean MFI for IL-10 from CD4+ T
cells in mice with and without infection is
equal (i.e., on average, there is no upregu-
lation of IL-10 in CD4+ T cells in response
to infection). The results of the hypothesis
test include a p value, the probability of
obtaining the observed results or, if the
null hypothesis is true, of obtaining more
extreme results. If the p value is small,
then there is a poor chance of getting
the observed results (here, the observed
difference in means) if the null hypothesis
is true, so the null hypothesis is rejected
and the result is said to be statistically sig-
nificant. If the p value is large, then there is
no evidence to reject the null hypothesis
and the result is said to be not statistically
significant.
The cut-off for the p value that deter-
mines significance is called the signifi-
cance level (unfortunately, this term is fre-
quently misappropriated by researchers,
who incorrectly use it to describe the
p value obtained from the test) or the al-
pha level. Its value, chosen at the design
stage of the study, is usually 0.05. This
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 95% confidence interval (CI) for the mean: loosely defined as the range of values within which the true population mean lies,
with 95% certainty. Provided the sample size is greater than about 10, it is approximately equal to the sample mean ± 23 the
standard error of the mean (SEM).
 Analysis of variance (ANOVA): a general term for analyses that compare the means of three or more groups of observations.
 Average: a summary measure of central tendency, such as the arithmetic mean (usually simply called the ‘‘mean;’’ equal to
the sum of all the observations divided by the number of observations) or the median (which is the middle observation in the
ordered set).
 Nonparametric (distribution-free) test: test that does not make any assumptions about the distribution of the data.
 Normal distribution: a symmetrical, theoretical, statistical distribution with many useful properties. The mean and median of
a normal distribution are equal.
 Random allocation (also called randomization): the units in the sample are randomly (i.e., by use of a method based on
chance) allocated to the different treatment groups.
 Random selection: each unit of analysis (e.g., mice or wells) is selected from the population by use of a method based on
chance and therefore has an equal probability of being selected.
 Robust test: the chance of making a mistake (i.e., of incorrectly either rejecting or not rejecting the null hypothesis) is hardly
affected when the test’s assumptions are violated.
 Standard error of the mean (SEM): a measure of precision of an estimate equal to the standard deviation divided by the square
root of the number of observations in the sample.
 Unit of analysis: the smallest unit of replication that can be randomly assigned a treatment.
 Variance: a measure of the variability or spread of a data set; it is equal to the square of the standard deviation (SD), which can
be thought of as a sort of average of the deviation of every observation from the mean.means that if p < 0.05, the null hypothesis
is rejected and the conclusion is that the
treatment means are different. In the
CD4+ T cell in vivo example (Box S1A Ex-
periment 1), p = 0.008, so the null hypoth-
esis is rejected; i.e., on average, infection
does alter the production of IL-10 in CD4+
T cells compared with the naive animals
(the group means for IL-10-producing
CD4+ T cells are 82.4 MFI and 66.0 MFI,
respectively).
It is important to recognize that lacking
evidence to reject the null hypothesis is
not the same as accepting the null hy-
pothesis—i.e., ‘‘absence of evidence is
not evidence of absence’’ (Altman and
Bland, 1995). There may be a real differ-
ence between the treatment means but
the sample size is too small to be able to
detect it as statistically significant.
The Assumptions Underlying
the Two-Sample t Test
If the assumptions underlying a statistical
test are not satisfied, the p value may be
incorrect and/or the test may fail to detect
as statistically significant a true treatment
effect. Although not all erroneous p values
lead to incorrect conclusions, statistical
methods applied inappropriately un-
doubtedly increase the chance of making
a mistake. The assumptions underlying
the two-sample t test (Petrie and Watson,
2006) are described next.The sample data should be randomly
selected from the population. If the units
of analysis are selected randomly from
the population, the sample should be rep-
resentative of the population about which
inferences are to be made. Unfortunately,
it is rarely possible in immunological stud-
ies to use random selection because
there is a tendency to use the units that
are available (e.g., to choose mice from
the cages in which they were bred or sup-
plied rather than from the larger popula-
tion). However, random allocation of the
units to the different treatment groups
may be used as a substitute for random
selection because the differences be-
tween treatment groups are akin to the
differences between random samples.
The use of random allocation avoids the
bias that might arise if the different treat-
ment groups are not balanced with regard
to those factors likely to influence re-
sponse. For example, docile mice may
have less testosterone than aggressive
mice, and testosterone has previously
been reported to be immunosuppressive
in some systems. Thus, if there is a pre-
ponderance of docile mice in one of the
two treatment groups (say, if they were
the first mice picked from the stock cage
and were all allocated to the same exper-
imental cage for treatment 1), the conclu-
sions drawn from the two-sample t test
comparing the mean CD4+ T cell IL-10ImmuMFI under two treatment regimes will be
biased; the difference in the mean re-
sponses in the two treatment groups
might be due to differences in amounts
of testosterone rather than to differences
between experimental treatments. To
avoid this problem, the mice should be
randomly allocated from the stock cage
into the experimental cages to ensure
that the docile mice are evenly distributed
in the two treatment groups. In terms of
in vitro work involving tissue culture plates,
complete randomization on a tissue cul-
ture plate is problematic and can lead to
physical plating errors. As a step toward
achieving randomization, researchers
could alter the order of the treatments on
the plate between experiments.
The two groups of data must also be in-
dependent. Independence of the obser-
vations between groups should not be
confused with independence of the ob-
servations within groups, the latter also
being a requirement of the two-sample t
test. In particular, there are theoretical is-
sues regarding the independence of ani-
mals housed in the same cage (Festing
and Altman, 2002). Correction of this
type of nonindependence may be difficult
to achieve in immunological experiments.
Another issue relates to the indepen-
dence of cell populations in wells. It is
common for immunologists to perform
hypothesis tests using the same cellnity 28, March 2008 ª2008 Elsevier Inc. 289
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than to replicate cell preparations. Repli-
cate wells in vitro are not independent,
because the cell population being tested
is the same preparation in all wells. Con-
sider, as an example, the generation of
IL-10-producing CD4+ T cells by pulsed
DCs in vitro (Box S1B). The desired infer-
ence from the experiment (CD4+ T cells
from individual mice) and the units of anal-
ysis (wells containing CD4+ T cells pooled
from different mice) are incongruous. Be-
cause the cells in each well are from the
same pooled CD4+ T cell population, the
only way to draw conclusions about
CD4+ T cell populations in general is to
a perform statistical analysis with data
from separately derived cell populations
(i.e., by repeating the experiments).
If there is dependence, either between or
within groups, it is not appropriate to per-
form the two-sample t test. Different statis-
tical tests, such as the paired t test or vari-
ous forms ofanalysisof variance, shouldbe
considered instead (http://www.isogenic.
info/index.html; Cox and Reid, 2000; Fest-
ing and Altman, 2002; Grafen and Hails,
2002; Howell, 1999; Mead, 1988).
It is also important that the data in each
group are normally distributed in the pop-
ulation. If the results of a two-sample t test
are to be valid, the data in each group
should come from a population of values
that approximately follows the normal dis-
tribution. A formal statistical hypothesis
test for normality, such as the Anderson-
Darling, Shapiro-Wilk, or Kolmogorov-
Smirnov tests, is unnecessary. Instead,
a visual impression of the symmetry of
a histogram (Figure S1B) or box-and-
whisker plot (Figure S1C) or a check that
the mean and median are approximately
equal is usually sufficient. By these crite-
ria, the box plots of MFI from CD4+ T cells
ex vivo (Figure S1C) suggest that the data
in each group are approximately normally
distributed. In contrast, the distribution of
the fluorescence intensity of individual
IL-10-producing CD4+ T cells from a sin-
gle infected animal (the histogram in
Figure S1B) is clearly not Normal; rather,
it is right-skewed, with a long tail to the
right. The mean fluorescence intensity of
90.8 is not a satisfactory summary mea-
sure of IL-10 fluorescence intensity in
the CD4+ T cells in this animal because
the mean is inflated by the values in the
tail; the median (fluoresence intensity of
59.2) is more appropriate.290 Immunity 28, March 2008 ª2008 ElsevieThe final assumption that must be con-
sidered is whether the variability is the
same in the two groups being compared
(i.e., whether there is homogeneity of var-
iance). Ideally, the variances of the obser-
vations in the two groups should be equal
(i.e., the data should exhibit homogeneity
of variance) when a two-sample t test is
performed. However, it might be possible,
depending on the software, to perform
a modified test that does not rely on the
assumption of equal variances.
Equality of variance is usually assessed
by a test of the null hypothesis that the two
population variances are equal by use of,
for example, Bartlett’s (Armitage et al.,
2002) or Levene’s test (Levene, 1960). A
nonsignificant result (usually if p > 0.05)
indicates that there is no evidence to
reject the null hypothesis. In the first
in vivo example (Box S1A Experiment 1
and Figure S1C), the variances of the
MFI in the groups of naive and infected
mice are estimated as 45.1 MFI and
255.6 MFI, respectively. Levene’s test
gives p = 0.07, which suggests that there
is insufficient evidence to reject the null
hypothesis that the variances of IL-10
MFI from CD4+ T cells in the two groups
are equal. Hence the two assumptions
underlying the two-sample t test, those
of normality and constant variance, are
satisfied in this example.
Violations of the Assumptions
Underlying the Two-Sample t Test
What happens when assumptions of nor-
mality and homogeneity of variance are
violated? The two-sample t test is fairly
robust to violations of the normality and
constant variance assumptions (Bland,
2000). In particular, heterogeneity of vari-
ance is not so important if the data are
normally distributed (Bland, 2000). Never-
theless, when the variances are very dif-
ferent (which could lead to a false-positive
finding), when the sample sizes in the two
groups are very disparate, and/or when
the sample sizes are so small (frequently
the case in immunological studies) that
is impossible to check the assumptions,
it might be better to consider alternatives
to the two-sample t test.
One approach is to transform each data
point mathematically (Bland and Altman,
1996; Grafen and Hails, 2002) and perform
the two-sample t test on the transformed
data, checking that the assumptions of
this new analysis are satisfied. For exam-r Inc.ple, if the logarithmic transformation (to
any base, but typically to base e or 10)
is taken of right-skewed observations
(when the distribution has a long tail to
the right; Figure S1B), the distribution of
the transformed data will usually be
approximately normal. The logarithmic
transformation and other transformations
can also correct for heterogeneity of vari-
ance (Petrie and Watson, 2006).
Another approach is to use a nonpara-
metric or distribution-free test. A nonpara-
metric or distribution-free analysis does
not make any assumptions about the
distribution of the data. It replaces the ob-
served data by their ranks in the ordered
set and is therefore not influenced by the
few extremely large (or small) values in
non-normally distributed data. A nonpara-
metric alternative to the two-sample t test
is the Mann-Whitney U test (equivalent to
the Wilcoxon rank sum test). However, if
all assumptions of the two-sample t test
are met, it is better to use the t test because
it has a greater ability to detect as signifi-
cant a real difference between groups.
One scenario where the independence
assumption could be violated is when the
data in the two groups are paired rather
than independent (e.g., pretreatment ver-
sus posttreatment samples). In this case
a paired t test is advocated instead of
the two-sample t test, provided the differ-
ences between the paired observations
are approximately normally distributed. If
normality is of concern, a paired t test
may be performed on suitably trans-
formed data or an appropriate nonpara-
metric test, such as the Wilcoxon Signed
Rank test or the Sign test, may be used.
All of the above considerations are
summarized in the flow-chart of Figure 1,
which may be used as a decision tool for
choosing the most appropriate test for
the comparison of two groups. A lack of
consideration for the assumptions of the
two-sample t test can lead to incorrect
conclusions. Consider a second in vivo
experiment in which the investigator
wants to assess whether IL-10 is upregu-
lated (Box S1A Experiment 2). The data
generated are skewed to the right in
both infected and uninfected groups of
mice, and there is heterogeneity of vari-
ance (Levene’s test gives p = 0.02). A
two-sample t test performed incorrectly
on these data gives p = 0.06, with insuffi-
cient evidence to show that, on average,
IL-10 is altered. However, an appropriate
Immunity
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of Observations
Various forms of analysis of variance should be used if there are more than two groups.analysis, such as the nonparametric
Mann-Whitney U test performed on the
raw data or the two-sample t test per-
formed on the logarithmically transformed
data (correcting for lack of normality and
heterogeneous variances), gives p =
0.04 in each case, indicating that, on aver-
age, CD4+ T cells do upregulate IL-10 in
response to this infection. This example
underlines the importance of correctly ap-




in the Two-Sample t Test
Sometimes, a difference in treatment
means appears biologically importantbut the results lack statistical significance,
perhaps because of an inadequate sam-
ple size and consequent low statistical
power. The power of a test, which in-
creases with larger samples, is the proba-
bility of detecting a real difference as sta-
tistically significant. A power calculation
to determine the optimal sample size at
the design stage of a study, before carry-
ing out an experiment, is essential. Such
a calculation is also required for most
grant applications. An optimal sample
size is one that is adequate to detect as
statistically significant a treatment effect
(e.g., a difference in means) of a given
magnitude but that is not so large that it
is wasteful of resources. A generally ac-
cepted view is that a test should have atImmunleast 80% power. It is not sensible to em-
bark on a study that is believed at the out-
set to have a lesser chance (say, 50%) of
finding a real effect statistically significant.
Calculation of the optimal sample size
depends on the proposed hypothesis
test (e.g., the two-sample t test) and
a specification of the power, significance
level, minimum treatment effect that is
considered important, and variation in
the data (see Box S3 and calculations
for the IL-10 example in Box S4). Several
different techniques can be used to deter-
mine the optimal sample size, including
computer programs such as nQuery Advi-
sor: Statistical Solutions (www.statsol.ie/
nquery/nquery.htm), tables (Machin
et al., 1997), relatively complex formulae
(Kirkwood et al., 2003), and a diagram
(Altman, 1982). In addition, Lehr (Lehr,
1992) devised simple formulae (provided
in Box S3) specifically for a 5% signifi-
cance level and an 80% or 90% power.
The optimal sample size should be justi-
fied by providing a power statement
(Box S4) that specifies the values of all
the factors that are incorporated into the
sample-size calculations. Then reviewers
and readers of the article can assess
whether the sample size used in the study
is sensible.
Reporting the Results of a Two-
Sample t Test
Details of how to report the results of a two-
sample t test are given in Box 2 and can
also be found in (Lang and Secic, 2006)
and in the CONSORT statement guidelines
(http://www.consort-statement.org). For
theexample shown in Box S1A Experiment
1 and in Figure S1, in addition to the power
statement, the reporting of the results
should state that there is evidence to
show that the CD4+ T cells from infected
animals have a significantly altered IL-10Box 2. Reporting Results from t Tests
In a complete presentation of the results of the two-sample t test the following should be included:
 The statistical test used should be named explicitly (i.e., ‘‘the two-sample t test,’’ not simply ‘‘a t test’’).
 An indication should be given that the underlying assumptions of the test have been validated (by use of a named transfor-
mation, if necessary).
 The sample size should be justified by a power calculation and accompanied by a power statement.
 The exact p value should be given, rather than an interval estimate of it or an asterisk (e.g., * to indicate 0.01 < P < 0.05).
 The estimated mean in each group, with its associated confidence interval, should be provided.
 An estimate of the difference in means, indicating the magnitude of the treatment effect, should be given with its associated
confidence interval.ity 28, March 2008 ª2008 Elsevier Inc. 291
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compared with naive animals (mean =
66.0 MFI, 95% CI 71.0 to 93.9 MFI): esti-
mated difference in means is 16.4 MFI,
95% CI 4.9 to 27.9 MFI, p = 0.008.
Multiple Testing and the Analysis
of Variance
The two-sample t test is used to compare
the means of two groups. However, when
it is of interest to compare the means in
three treatment groups, A, B and C (e.g.,
A = infected, B = sham-injected, and C =
vaccinated), it is inappropriate to perform
all pairwise two-sample t tests (i.e., A ver-
sus B, A versus C, and B versus C). This is
because as more tests are performed, it is
more likely that a statistically significant
result will occur on the basis of chance
alone (Bender and Lange, 2001; Grafen
and Hails, 2002).
The correct procedure in these circum-
stances is to start by performing a one-
way analysis of variance (ANOVA), a
global test of the null hypothesis that all
(three) group means are equal. If the re-
sult of this ANOVA is not significant (typi-
cally if p > 0.05), no further testing is re-
quired. However, if the one-way ANOVA
produces a significant result with p <
0.05, this implies that at least two of the
group means are different, and it is neces-
sary to find out where any differences lie.
This is achieved by performing post hoc
tests (such as those attributed to Bonfer-
roni, Scheffe´, Dunnett, and Tukey) that
compare the means of all relevant pairs
of groups, but each test adjusts the p
value to take into account the multiple
comparisons and thereby avoids a spuri-
ously significant result.
There are many different forms of
ANOVA, the simplest being the one-way
ANOVA, which can be thought of as an
extension to the two-sample t test when
more than two group means are to be
compared. More complicated forms (Ed-
wards, 1993; Lindman, 1992; Weber and
Skillings, 2000) should be employed
when other factors need to be taken into
consideration, such as the cages in which
experimental animals are housed, the
wells in which cell preparations are placed,
and the replications of an experiment.
Conclusion
Failure to take stock of the statistical as
well as the biological significance of data
can ultimately be a waste of time and292 Immunity 28, March 2008 ª2008 Elseviemoney and, where animals or patients
are involved, can also raise ethical issues
(Festing and Altman, 2002). At present,
however, errors in violation of both statis-
tical science and editorial policy appear to
be common in the primary immunological
literature. For example, many articles
contain quantitative data from which con-
clusions are drawn about treatment ef-
fects in the absence of inferential statisti-
cal analysis, and others include significant
p values without any information about
the units of analysis, the sample sizes,
the tests used, or their validity (Olsen,
2003). Unfortunately, these errors can
lead to incorrect conclusions, especially
for p values very close to 0.05 (i.e., of mar-
ginal statistical significance). There ap-
pears to be much room for improvement
of statistical practice in immunology.
Giving proper consideration to the use
of the two-sample t test, as outlined in
this article, will improve the evaluation of
treatment effects in immunological data
and reduce the chances of drawing erro-
neous conclusions. Reviewers of manu-
scripts also need to be statistically in-
formed, in order to judge whether the
amount of variability in experimental data
is acceptable (Altman, 1998) and the use
of the two-sample t test is justified. In-
deed, authors, reviewers, and editors alike
must take steps to improve the rigor with
which scientists t test the immune system.
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One figure and four boxes can be found online with
this article at http://www.immunity.com/cgi/
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